Literature DB >> 14640829

Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences.

Kimberly A Blanchard1, Jon Morgenstern, Thomas J Morgan, Erich W Lobouvie, Donald A Bux.   

Abstract

Negative consequences are an important component of the substance use change process, yet no standardized measure exists to assess consequences of use. This study evaluated the psychometric properties of the Inventory of Drug Use Consequences, a self-report measure assessing drinking and drug use consequences. Participants (N=252) were assessed at entry into outpatient substance abuse treatment. Items loaded strongly on 1 factor, and internal consistency of the total scale was high. Fifteen items with the highest correlations with the total scale were chosen to represent the construct. The shortened measure exhibited good internal consistency, convergent and discriminant validity, and detected change over time and may be the measure of substance use consequences that is lacking in the field.

Entities:  

Mesh:

Year:  2003        PMID: 14640829     DOI: 10.1037/0893-164X.17.4.328

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  60 in total

1.  Treating depression and substance use: a randomized controlled trial.

Authors:  Sarah B Hunter; Katherine E Watkins; Kimberly A Hepner; Susan M Paddock; Brett A Ewing; Karen C Osilla; Suzanne Perry
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers.

Authors:  Brian D Kiluk; Jessica A Dreifuss; Roger D Weiss; Jon Morgenstern; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2012-05-28

3.  A test of core psychopathic traits as a moderator of the efficacy of a brief motivational intervention for substance-using offenders.

Authors:  Marc T Swogger; Kenneth R Conner; Eric D Caine; Nicole Trabold; Melissa N Parkhurst; Laurel M Prothero; Stephen A Maisto
Journal:  J Consult Clin Psychol       Date:  2016-01-04

4.  The impact of depression on abstinence self-efficacy and substance use outcomes among emerging adults in residential treatment.

Authors:  Brenna L Greenfield; Kamilla L Venner; John F Kelly; Valerie Slaymaker; Angela D Bryan
Journal:  Psychol Addict Behav       Date:  2012-01-30

5.  Reliability and validity of the alcohol short index of problems and a newly constructed drug short index of problems.

Authors:  Arthur I Alterman; John S Cacciola; Megan A Ivey; Brian Habing; Kevin G Lynch
Journal:  J Stud Alcohol Drugs       Date:  2009-03       Impact factor: 2.582

6.  Temporal associations between substance use and delinquency among youth with a first time offense.

Authors:  Sarah B Hunter; Jeremy N V Miles; Eric R Pedersen; Brett A Ewing; Elizabeth J D'Amico
Journal:  Addict Behav       Date:  2014-03-12       Impact factor: 3.913

7.  Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.

Authors:  Corey R Roos; Sarah Bowen; Katie Witkiewitz
Journal:  J Consult Clin Psychol       Date:  2017-11

8.  Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support.

Authors:  Magdalena Kulesza; Katherine E Watkins; Allison J Ober; Karen C Osilla; Brett Ewing
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

9.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

10.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.